Karyopharm Stock Is Trading Higher On Updated Eltanexor Data In Patients With Blood Disorder
Apellis-Sobi Partnered Pegcetacoplan Shows Clinically Meaningful Improvements in Rare Blood Disorder Study
William Blair Values Global Blood Therapeutics' Stock At $80
Morgan Stanley: Global Blood Therapeutics 'Clearly Encouraged' By Sickle Cell Therapy Data